1.1150.00% ( 0.000 )
Delisted: Nov 13, 09:20:00 (EDT)Valuation
Current ValuationThe current P/E ratio is 3.92, within the reasonable range, cheaper than 32.67% of the time in the past 5 years, and the industry ranks 1/23, the industry Median 8.77.
3.92xP/E
--Stock price
3.92xP/E
Stock price--
Historical Valuation
P/E ratioTypical rangeMedian
- P/E ratio
- -0.72x
- Typical range
- -3.35x–3.92x
Peer P/E ratio Comparison
It displays how the company's P/E ratio compares to top companies within its industry.
Industry median 8.77x
06121824
Industry P/E ratio Comparison
This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
Industry median 8.77x
0x10x20x30x40x50x
| Name/Symbol | |||
|---|---|---|---|
SGRYUSSurgery Partners | -40.55x | 7.94% | $3.53B |
ACHCUSAcadia Healthcare | -3.11x | 107.27% | $3.51B |
BKDUSBrookdale Senior Living | -58.53x | 95.89% | $2.19B |
SNDAUSSonida Senior Living | -10.48x | 12.24% | $1.59B |
USPHUSU.S. Physical Therapy | -73.90x | 100.38% | $1.49B |
STLNUSStarling Oncology | -11.89x | 50.93% | $356.97M |
RNVAUSRennova Health, Inc. | -- | -- | $40.55K |
IVPRUSInspire Veterinary Partners, Inc. | -0.00x | -- | $22.44K |
Risk Warning
Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.
